Clinical Trials Browser

Unspecified Adult Solid Tumor, Protocol Specific

NCT00731276 2017-03-31

Irinotecan in Treating Asian Patients With Solid Tumors

Phase 1 Completed

18 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00026195 2016-07-06

Irinotecan in Treating Aging Patients With Solid Tumors

Phase 1 Completed

140 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00547547 2015-11-06

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Phase 1 Completed

22 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00020488 2015-04-30

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00046917 2014-02-24

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

13 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00054288 2014-01-13

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00112892 2014-01-13

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004051 2013-12-19

Irinotecan in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005791 2013-12-19

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00021073 2013-12-11

Combination Chemotherapy in Treating Patients With Advanced Cancer

Phase 1 Completed

90 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00002939 2013-09-05

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

Phase 1 Completed

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003742 2013-06-21

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00074321 2013-06-06

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

Phase 1 Completed

84 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00042874 2013-06-04

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

77 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00119236 2013-06-04

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

48 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003711 2013-05-30

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00084877 2013-05-16

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003109 2013-04-17

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Phase 1 Completed

39 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006000 2013-01-31

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00079352 2013-01-25

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

24 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00062127 2013-01-24

Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

35 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003710 2012-08-09

Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

12 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005068 2011-08-03

Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00020748 2011-03-24

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00024141 2011-03-07

Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00047242 2010-08-09

UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006465 2010-06-11

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

22 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006485 2009-12-15

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00544063 2009-12-15

Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Phase 1 Unknown

33 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004923 2009-08-25

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

Phase 1/2 Completed

47 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Irinotecan in Treating Asian Patients With Solid Tumors

Irinotecan in Treating Aging Patients With Solid Tumors

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Irinotecan in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Cancer

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors

Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors

UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors